RBC Capital analyst Gregory Renza maintained a Buy rating on Nuvation Bio (NUVB – Research Report) today and set a price target of $6.00.

Fintel reports that on November 5, 2024, RBC Capital downgraded their outlook for Verrica Pharmaceuticals (NasdaqGM:VRCA) ...

In a report released on November 5, Rishi Jaluria from RBC Capital maintained a Sell rating on Palantir Technologies (PLTR – Research ...

Former RBC advisor claims firm discriminated against her, and the timing of her firing could let the firm take a large portion of her book without compensation.

ConocoPhillips is exploring a sale of some of its shale operations in the Permian Basin worth more than $1 billion, two years ...

Singapore’s asset growth in 2019 and 2022 could spark promise for Hong Kong. Drawing from Singapore’s experience with its ...

RBC Capital lowered the firm’s price target on Magna (MGA) to $42 from $47 and keeps a Sector Perform rating on the shares as ...

Fidelity National Information Services beats Q3 estimates, and raises full-year outlook Analysts maintain rating.

RBC Capital initiated coverage of StandardAero (SARO) with an Outperform rating and $37 price target StandardAero is the largest independent engine maintenance, repair and overhaul provider ...

Analysts lower price target for BP after Q3 results show revenue miss and production decline. Focus on deleveraging over growth.

Investing.com -- Shares of Burberry (LON: BRBY) saw a rise on Wednesday following an upgrade by RBC Capital Markets to an "outperform" rating from a "sector perform” rating, accompanied by a price ...

Forbes Advisor ranks the best business bank accounts in Canada to determine which best serves businesses, large or small.